BP Lipid 586 is a unique ionizable lipid developed by BroadPharm to enable our clients' next-generation R&D. This compound incorporates the key desirable features of a heterocyclic azetidine head group, a two carbon spacer, two linoleic acid tails and a biodegradable yet robus carbamate linkage. These structural features are intended to enable SAR studies and optimize the formulation of lipid nanoparticles for drug and mRNA delivery applications.
Usually ships within 24 hours.